The global spread of dengue virus has immunologists and public-health experts debating the best way to curb infection.
The Scientist
Most Recent
Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?
Researchers have created a molecule that helps nanoparticles evade immune attack and could improve drug delivery.
Three Silicon Valley entrepreneurs are offering $3 million to scientists demonstrating excellence in biology and medical research.
Disruptions in the interaction between nuclear and mitochondrial DNA can lead to deficiencies in the mitochondrial energy-generating process, affecting fitness.
The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
Protein aggregates in the brains of some people with dementia or motor neuron disease have a surprising origin.
Tuberculosis bacteria find shelter from drugs and the body’s defenses in bone marrow stem cells.
Meet the bacterium that pulls gold ions out of solution and forms tiny nuggets of the precious metal.
One of the most advanced tuberculosis vaccines has failed to protect infants from getting the disease in a clinical trial, but it may be effective in adults.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
